WATSON
FDA Approves Unknown Drug — WATSON LABS FLORIDA
Watson Pharmaceuticals (now Actavis) received final approval from the U.S. FDA for Abbreviated New Drug Application (ANDA) 075961 on January 25, 2002....
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
URONOVA
FDA Approves VABRINTY — URONOVA PHARMACEUTICALS, INC.
# FDA Approves VABRINTY (Leuprolide Acetate) for Subcutaneous Administration Uronova Pharmaceuticals, Inc. received FDA approval for VABRINTY (leupro...
AUROBINDO
FDA Approves Unknown Drug — AUROBINDO PHARMA USA
Aurobindo Pharma USA has secured FDA approval to market a generic drug with ANDA 076152, moving the company to fulfill a specific market need. This re...
LGM
FDA Approves ASCOMP WITH CODEINE — LGM PHARMA SOLUTIONS, LLC
LGM Pharma Solutions, LLC (LGM) obtained FDA approval today for ORAL Ascomp with Codeine tablets (generic butalbital, aspirin, caffeine, and codeine p...
Prasco
FDA Approves DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Prasco Laboratories
# FDA Approves Amphetamine Combination Formulation for Prasco Laboratories Prasco Laboratories received FDA approval for its oral amphetamine combina...
Kenvue
FDA Approves ZYRTEC-D — Kenvue Brands LLC
Kenvue Brands LLC secured a competitive edge in the oral allergy market with the 2001 FDA approval of ZYRTEC-D, allowing the company to leverage a bra...
RISING
FDA Approves Unknown Drug — RISING
RISING announced today that the FDA has approved its ANDA, a regulatory milestone that the company expects will bolster its financial performance and ...
USAntibiotics,
FDA Approves AUGMENTIN ES-600 — USAntibiotics, LLC
**USAntibiotics, LLC** has secured FDA clearance for Augmentin ES-600 (amoxicillin and clavulanate potassium), reinforcing the company's position in t...
SpecGx
FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — SpecGx LLC
SpecGx LLC has secured an FDA approval for the generic version of Acetaminophen and Codeine Phosphate oral tablets, expected to expand its current por...
Teva
FDA Approves TREXALL — Teva Women's Health LLC
# FDA Approves Teva Women's Health's Oral Methotrexate Sodium Product Teva Women's Health LLC received FDA approval for TREXALL (methotrexate sodium)...
RISING
FDA Approves Unknown Drug — RISING
On December 19, 2000, Rising received FDA approval for ANDA075725, marking a significant commercial entry into the market. This approval is expected t...
Strides
FDA Approves DOXYCYCLINE — Strides Pharma Science Limited
# FDA Approves Doxycycline ANDA for Strides Pharma Science Limited Strides Pharma Science Limited has received FDA approval for its abbreviated new d...
Kenvue
FDA Approves IMODIUM MULTI-SYMPTOM RELIEF — Kenvue Brands LLC
# FDA Approval Newswire Kenvue Brands LLC has received FDA approval for IMODIUM Multi-Symptom Relief, an oral combination formulation of loperamide h...
Fresenius
FDA Approves VENOFER — Fresenius Medical Care Holdings, Inc.
# FDA Approves Fresenius Medical Care's Venofer for Intravenous Iron Supplementation Fresenius Medical Care Holdings, Inc. received FDA approval for ...
Meitheal
FDA Approves LEUPROLIDE ACETATE — Meitheal Pharmaceuticals Inc
# FDA Approves Generic Leuprolide Acetate for Meitheal Pharmaceuticals Meitheal Pharmaceuticals Inc received FDA approval for its generic leuprolide ...
Aurobindo
FDA Approves DOXAZOSIN — Aurobindo Pharma Limited
Aurobindo Pharma Limited announced the approval of an Abbreviated New Drug Application for doxazosin mesylate tablets to be marketed immediately. This...
Advagen
FDA Approves CLONAZEPAM — Advagen Pharma Ltd
Advagen Pharma Ltd obtained FDA approval on October 6, 2000, for its generic oral Clonazepam tablet under ANDA075468. The clearance is expected to bol...
SpecGx
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — SpecGx LLC
SpecGx LLC secured FDA approval for filing ANDA040405, gaining market access for generic HYDROCODONE BITARTRATE AND ACETAMINOPHEN. The entry of this g...
AbbVie
FDA Approves DEPAKOTE ER — AbbVie Inc.
AbbVie Inc. solidified its foothold in the anticonvulsant market with the FDA approval of DEPAKOTE ER, the once-daily extended-release version of diva...
Haleon
FDA Approves ABREVA — Haleon US Holdings LLC
# FDA Approves Haleon's ABREVA (Docosanol) for Cold Sore Treatment Haleon US Holdings LLC has received FDA approval for ABREVA (docosanol), a topical...